Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission... Nucl Med Mol Imaging (2014) 48:114–120 DOI 10.1007/s13139-013-0255-z ORIGINAL ARTICLE Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer Jae Pil Hwang & Ilhan Lim & Im II Na & Eung Ho Cho & Byung II Kim & Chang Woon Choi & Sang Moo Lim Received: 11 April 2013 /Revised: 16 November 2013 /Accepted: 20 November 2013 /Published online: 6 December 2013 Korean Society of Nuclear Medicine 2013 Abstract 0.0400). On Kaplan-Meier analysis, SUVmax (p =0.0400), Objective The aim of this study is to investigate the prognos- stage (p =0.0001), CA19-9 (p =0.013), CEA (p =0.006), LN tic value of F-18 fluorodeoxyglucose (F-18 FDG) positron metastasis (p =0.0001), distant metastasis (p =0.0020), type of emission tomography (PET)/computed tomography (CT) in treatment (p =0.0001) were significantly associated with over- gallbladdercancerpatients. all survival. Multivariate analysis study revealed that the Methods From June 2004 to June 2010, a total of 50 patients patients with lower SUVmax measured from initial staging with gallbladder cancer who underwent diagnostic staging PET/CT (p =0.0380), no LN metastasis (p =0.0260), a lower with F-18 FDG PET/CT following curative or palliative treat- stage (p =0.026) and curative treatment http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nuclear Medicine and Molecular Imaging Springer Journals

Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer

Loading next page...
 
/lp/springer-journals/prognostic-value-of-suvmax-measured-by-fluorine-18-fluorodeoxyglucose-cavC1zjqwg

References (29)

Publisher
Springer Journals
Copyright
Copyright © 2013 by Korean Society of Nuclear Medicine
Subject
Medicine & Public Health; Nuclear Medicine; Imaging / Radiology; Orthopedics; Cardiology; Oncology
ISSN
1869-3474
eISSN
1869-3482
DOI
10.1007/s13139-013-0255-z
pmid
24900151
Publisher site
See Article on Publisher Site

Abstract

Nucl Med Mol Imaging (2014) 48:114–120 DOI 10.1007/s13139-013-0255-z ORIGINAL ARTICLE Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer Jae Pil Hwang & Ilhan Lim & Im II Na & Eung Ho Cho & Byung II Kim & Chang Woon Choi & Sang Moo Lim Received: 11 April 2013 /Revised: 16 November 2013 /Accepted: 20 November 2013 /Published online: 6 December 2013 Korean Society of Nuclear Medicine 2013 Abstract 0.0400). On Kaplan-Meier analysis, SUVmax (p =0.0400), Objective The aim of this study is to investigate the prognos- stage (p =0.0001), CA19-9 (p =0.013), CEA (p =0.006), LN tic value of F-18 fluorodeoxyglucose (F-18 FDG) positron metastasis (p =0.0001), distant metastasis (p =0.0020), type of emission tomography (PET)/computed tomography (CT) in treatment (p =0.0001) were significantly associated with over- gallbladdercancerpatients. all survival. Multivariate analysis study revealed that the Methods From June 2004 to June 2010, a total of 50 patients patients with lower SUVmax measured from initial staging with gallbladder cancer who underwent diagnostic staging PET/CT (p =0.0380), no LN metastasis (p =0.0260), a lower with F-18 FDG PET/CT following curative or palliative treat- stage (p =0.026) and curative treatment

Journal

Nuclear Medicine and Molecular ImagingSpringer Journals

Published: Dec 6, 2013

There are no references for this article.